Signos Secures 20M Funding to Expand AI Health Tracking Amid GLP1 Weight Loss Boom Julian Alvarez Contract Standoff FC Barcelona Alerted as Atletico Madrid Star Refuses Extension Charter Communications Announces Improved Buyout Deal for Liberty Broadband Dow Jones Hits New Record Closing High AI Rally Pauses as Tech Stocks Lag Global Leaders Watch Closely as TrumpXi Summit Approaches From Singapore to Brussels Market Update Zimmer Biomet AnheuserBusch InBev and Viatris See Mixed Trading Activity WKC Q1 2026 Earnings Massive EPS Beat Drives Consideration but Shares Edge Lower Nasdaq Inc NDAQ Q1 2026 Earnings Modest EPS Beat Amid Market Volatility MSEX Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher CYD Q3 2020 Earnings EPS Slightly Below Estimates Stock Rises 3 CLNN Q1 2026 Earnings EPS Beat Driven by Cost Control Amid No Revenue TOON Q3 2018 Earnings WiderThanExpected Loss Despite Stock Rally First Internet Bancorp INBK Retreats Slightly as Stock Tests Nearby Support Levels Galata Acquisition Corp II LATA Holds Steady at 1005 Amid PreCombination Stasis trivago NV TRVG Edges Lower Amid Subdued Trading Activity Newbury Street II Acquisition Corp Warrant NTWOW Holds Steady at 018 Traders Eye Tight Trading Range Solana Company HSDT Holds Near Support as Price Action Consolidates in Tight Range Burberry Shares Climb on Speculation of Potential Moncler Bid Centuri Holdings Inc CTRI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Response Highlander Silver Corp HSLV Gains 238 as Silver Sector Momentum Builds SES AI Q1 2026 Earnings Wider Loss Per Share Misses Estimates as PreRevenue Battery Developer Continues RD Investments KOSS Q1 2026 Earnings Navigating a Transitional Period as Focus Shifts to Brand Reinvention Financial Abuse in Relationships The Case of Ruth Dodsworth and the Hidden Economic Toll ABCB Q1 2026 Earnings EPS Beats Estimates by 257 Amid Stable Market Response NTGR Q1 2026 Earnings Strong EPS Surprise Amid Strategic Shift Vivani Medical Q1 2026 Earnings Slight EPS Beat Fails to Stem Stock Decline as PreRevenue Biotech Navigates Development Pipeline ORKT Q0 2024 Earnings Substantial EPS Miss as Revenue Remains Undisclosed